9 Results for "

SOS2

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "SOS2" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-RS13577
Research Areas:  

Others

SOS2 Human Pre-designed siRNA Set A contains three designed siRNAs for SOS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS19958
Research Areas:  

Others

Sos2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sos2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-168480
CAS No.: 690696-36-7
Target:  

Ras

Research Areas:  

Cancer

SOS2 ligand 1(compound 2) is a selective ligand of son of sevenless 2 (SOS2) with an KD value of 4.6 µM .
loading...
    loading...
Cat. No.: HY-RS26460
Research Areas:  

Others

Sos2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sos2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-145737A
Purity:  99.38%
Target:  

PROTACs SOS1 Ras PERK

Research Areas:  

Cancer

PROTAC SOS1 degrader-1 TFA is a degrader of SOS1 PROTAC, with a DC50 of 98.4 nM and a Kd value of 44 nM. PROTAC SOS1 degrader-1 TFA induces the formation of a ternary complex with SOS1 and the VCB E3 ubiquitin ligase complex, thereby promoting the ubiquitination and proteasomal degradation of SOS1. PROTAC SOS1 degrader-1 TFA reduces KRAS-GTP levels, inhibits the phosphorylation of ERK in the RAS-RAF-MEK-ERK pathway, and suppresses the proliferation of cancer cells carrying KRAS mutations. PROTAC SOS1 degrader-1 TFA inhibits tumor growth in mouse xenograft models. PROTAC SOS1 degrader-1 TFA can be used for the research of KRAS-driven cancers .
loading...
    loading...
Cat. No.: HY-145737
CAS No.: 2913185-35-8
Target:  

PROTACs SOS1 Ras PERK

Research Areas:  

Cancer

PROTAC SOS1 degrader-1 is a degrader of SOS1 PROTAC, with a DC50 of 98.4 nM and a Kd value of 44 nM. PROTAC SOS1 degrader-1 induces the formation of a ternary complex with SOS1 and the VCB E3 ubiquitin ligase complex, thereby promoting the ubiquitination and proteasomal degradation of SOS1. PROTAC SOS1 degrader-1 reduces KRAS-GTP levels, inhibits the phosphorylation of ERK in the RAS-RAF-MEK-ERK pathway, and suppresses the proliferation of cancer cells carrying KRAS mutations. PROTAC SOS1 degrader-1 inhibits tumor growth in mouse xenograft models. PROTAC SOS1 degrader-1 can be used for the research of KRAS-driven cancers .
loading...
    loading...
Cat. No.: HY-161173
CAS No.: 2836273-61-9
Target:  

PROTACs SOS1 Ras

Research Areas:  

Cancer

PROTAC SOS1 degrader-5 is a potent SOS1 PROTAC degrader with a DC50 value of 13 nM. PROTAC SOS1 degrader-5 induces CRBN-dependent ubiquitination and degradation of SOS1 protein, inhibits the proliferation of KRAS G12C-mutated cancer cells, and suppresses tumor growth in xenograft models. PROTAC SOS1 degrader-5 can be used in studies related to KRAS G12C-mutated non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-161450
Target:  

PROTACs SOS1 ERK

Research Areas:  

Cancer

LHF418 is a SOS1 PROTAC degrader that induces the degradation of the target protein SOS1 by recruiting cereblon. LHF418 promotes the formation of the SOS1-PROTAC-CRBN ternary complex and induces SOS1 degradation in a cereblon- and proteasome-dependent manner. LHF418 inhibits EGF-induced ERK1/2 phosphorylation and the clonogenic growth of KRAS-mutant cancer cells. LHF418 can be used in studies related to SOS1-targeted protein degradation and KRAS-driven tumors .
loading...
    loading...
Cat. No.: HY-184855
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

(S,S,S,S)-AHPC-Me is an E3 ligase ligand that can be used in research related to PROTAC synthesis, such as serving as the E3 ligase ligand for (4S)-PROTAC SOS1 degrader-1 (HY-144657) .
loading...
    loading...